About Ablacon

Ablacon provides the OptiMap™ System, a 510(k) cleared electrographic flow mapping solution that utilizes AI to analyze unipolar electrogram signals for atrial fibrillation. This technology enables precise identification of active arrhythmia sources, improving treatment strategies for patients with complex atrial arrhythmias.

```xml <problem> Current methods for treating atrial fibrillation (AFib) may not effectively target the specific arrhythmia sources outside the pulmonary veins, leading to incomplete ablation and recurrence, especially in complex cases. A one-size-fits-all anatomical approach risks over-ablating tissue while missing critical triggers or drivers of the arrhythmia. </problem> <solution> The OptiMap System by Cortex offers an electrographic flow (EGF) mapping solution that uses AI to visualize and analyze the electrical activity in the atria during AFib. By processing unipolar electrogram signals from a 64-electrode basket catheter, the system reconstructs the spatiotemporal patterns of electrical conduction. This allows physicians to identify active arrhythmia sources, such as divergent excitation waves, and assess the consistency of wavefront propagation, which may indicate the underlying atrial substrate. The OptiMap System aims to personalize AFib treatment by enabling targeted ablation strategies that focus on the specific pathophysiologic mechanisms driving the arrhythmia in each patient. </solution> <features> - AI-powered electrographic flow (EGF) mapping from a single minute of unipolar electrogram signals - 64-electrode OptiMap basket catheter for comprehensive atrial signal acquisition - Optical flow algorithm for spatiotemporal reconstruction of chaotic electrical conduction - Identification of active AFib sources outside the pulmonary veins - Visualization of wavefront propagation consistency to assess atrial substrate - Seamless workflow integration into existing electrophysiology procedures </features> <target_audience> The primary users are electrophysiologists and other physicians treating patients with complex atrial arrhythmias, particularly those who have not responded to conventional pulmonary vein isolation (PVI) techniques. </target_audience> ```

What does Ablacon do?

Where is Ablacon located?

Ablacon is based in Wheat Ridge, United States.

When was Ablacon founded?

Ablacon was founded in 2015.

How much funding has Ablacon raised?

Ablacon has raised 90000000.

Location

Wheat Ridge, United States

Founded

2015

Funding

90000000

Employees

31 employees

Major Investors

Hellman & Friedman, Kohlberg Kravis Roberts

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Ablacon

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

ablacon.com 7K+

Crunchbase

Founded 2015 – Wheat Ridge, United States

Funding

Estimated Funding

$50M+

Major Investors

Hellman & Friedman, Kohlberg Kravis Roberts

Team (30+)

No team information available.

Company Description

Problem

Current methods for treating atrial fibrillation (AFib) may not effectively target the specific arrhythmia sources outside the pulmonary veins, leading to incomplete ablation and recurrence, especially in complex cases. A one-size-fits-all anatomical approach risks over-ablating tissue while missing critical triggers or drivers of the arrhythmia.

Solution

The OptiMap System by Cortex offers an electrographic flow (EGF) mapping solution that uses AI to visualize and analyze the electrical activity in the atria during AFib. By processing unipolar electrogram signals from a 64-electrode basket catheter, the system reconstructs the spatiotemporal patterns of electrical conduction. This allows physicians to identify active arrhythmia sources, such as divergent excitation waves, and assess the consistency of wavefront propagation, which may indicate the underlying atrial substrate. The OptiMap System aims to personalize AFib treatment by enabling targeted ablation strategies that focus on the specific pathophysiologic mechanisms driving the arrhythmia in each patient.

Features

AI-powered electrographic flow (EGF) mapping from a single minute of unipolar electrogram signals

64-electrode OptiMap basket catheter for comprehensive atrial signal acquisition

Optical flow algorithm for spatiotemporal reconstruction of chaotic electrical conduction

Identification of active AFib sources outside the pulmonary veins

Visualization of wavefront propagation consistency to assess atrial substrate

Seamless workflow integration into existing electrophysiology procedures

Target Audience

The primary users are electrophysiologists and other physicians treating patients with complex atrial arrhythmias, particularly those who have not responded to conventional pulmonary vein isolation (PVI) techniques.